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Branched-Chain Amino Acid
Negatively Regulates KLF15
Expression via PI3K-AKT Pathway
Yunxia Liu †, Weibing Dong †, Jing Shao, Yibin Wang, Meiyi Zhou* and Haipeng Sun*
Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Department of Pathophysiology,
Shanghai Jiao Tong University School of Medicine, Shanghai, China
Recent studies have linked branched-chain amino acid (BCAA) with numerous metabolic
diseases. However, the molecular basis of BCAA’s roles in metabolic regulation remains
to be established. KLF15 (Krüppel-like factor 15) is a transcription factor and master
regulator of glycemic, lipid, and amino acids metabolism. In the present study, we found
high concentrations of BCAA suppressed KLF15 expression while BCAA starvation
induced KLF15 expression, suggesting KLF15 expression is negatively controlled by
BCAA.Interestingly, BCAA starvation induced PI3K-AKT signaling. KLF15 induction by
BCAA starvation was blocked by PI3K and AKT inhibitors, indicating the activation of
PI3K-AKT signaling pathway mediated the KLF15 induction. BCAA regulated KLF15
expression at transcriptional level but not post-transcriptional level. However, BCAA
starvation failed to increase the KLF15-promoter-driven luciferase expression, suggesting
KLF15 promoter activity was not directly controlled by BCAA. Finally, fasting reduced
BCAA abundance in mice and KLF15 expression was dramatically induced in muscle and
white adipose tissue, but not in liver. Together, these data demonstrated BCAA negatively
regulated KLF15 expression, suggesting a novel molecular mechanism underlying
BCAA’s multiple functions in metabolic regulation.
Keywords: BCAA, Klf15, PI3K, Akt, regulation
INTRODUCTION
Branched chain amino acid (BCAA), including leucine, isoleucine, and valine, are essential amino
acids. In addition to building proteins, numerous metabolic functions of BCAA have been
investigated (Nair and Short, 2005). BCAA modulates insulin and glucagon secretion in pancreas
(Meijer and Dubbelhuis, 2004). Increasing BCAA intake was often associated with positive effects
on body weight and glucose homeostasis, attenuating obesity and type 2 diabetes mellitus T2DM
(Lynch and Adams, 2014). BCAA regulates protein synthesis and degradation in various tissues. In
addition, BCAA influences brain function by participating in synthesis and transport of glutamate,
an important excitatory neurotransmitter, and by modifying large, neutral amino acid transport at
the blood–brain barrier (Joshi et al., 2006).
Branched chain amino acid (BCAA) has recently been linked with numerous diseases. Elevated
circulating levels of BCAA have been associated with an increased risk of T2DM and insulin
resistance in humans (Newgard et al., 2009; Huang et al., 2011; Melnik, 2012; Lu et al., 2013;
Lynch and Adams, 2014). Defect of BCAA catabolism promotes heart failure progression and
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associated with cardiovascular diseases (Shah et al., 2010; Sun
et al., 2016). Impaired BCAA transportation and metabolism
is associated with autism (Novarino et al., 2012; Târlungeanu
et al., 2016). Elevated plasma BCAA levels have been found
in early pancreatic ductal adenocarcinoma patients, supporting
formation of non–small cell lung carcinoma and growth of
pancreatic ductal adenocarcinoma (Mayers et al., 2014, 2016;
Dey et al., 2017). The novel roles of BCAA in metabolic,
cardiovascular, neurological diseases, and cancer are being
investigated.
Little is known about the molecular basis of BCAA’s function
in cells. BCAA, especially leucine, is one key regulator of
target of rapamycin complex 1 (TORC1) signaling, which
is the central component of a complex signaling network
of cell growth and metabolism (Saxton and Sabatini, 2017).
Recently, SESN2 has been reported to be a cytoplasmic leucine
sensor to activate TORC1 (Saxton et al., 2016; Wolfson
et al., 2016). It has been implicated that BCAA enhanced
TORC1 activation and contributed to insulin resistance
(Newgard et al., 2009). In Maple Syrup Urine Disease and
heart failure, branched-chain alpha keto acid (BCKA), the
intermediate metabolite of BCAA catabolism, suppressed
mitochondrial respiration and induced oxidative stress in
cells (Funchal et al., 2006; Ribeiro et al., 2007; Sun et al.,
2016). Other than these observations, the molecular basis
of BCAA’s roles in metabolic regulation remains to be fully
explored.
KLF15 (Krüppel-like factor 15) is a transcription factor
and a master regulator of metabolism. KLF15-deficient mice
have impaired ability to catabolize muscle BCAAs as fuel for
gluconeogenic flux during fasting (Gray et al., 2007). In addition,
during sustained aerobic exercise, KLF15-deficient mice fail to
augment muscle lipid utilization and consequently have impaired
endurance exercise capacity (Haldar et al., 2012; Prosdocimo
et al., 2014). During adipocyte differentiation, KLF15 is
dramatically induced and indispensable for the differentiation
(Mori et al., 2005). Under fasting condition, KLF15 is induced
and inhibits the expression of SREBP-1C in liver, suppressing
lipogenesis (Takeuchi et al., 2016). KLF15 regulates the insulin-
sensitive glucose transporter GLUT4 expression (Gray et al.,
2002). KLF15 is one key regulator of circadian homeostasis
and controls the homeostasis of amino acids during circadian
cycle (Jeyaraj et al., 2012; Zhang et al., 2015). In addition,
KLF15 controlled the circadian homeostasis of bile acid synthesis.
KLF15 deficient mice produced much less bile acids that slowed
down the absorption of lipid and other nutrients (Han et al.,
2015). Thus, KLF15 is a master regulator of circadian and
metabolic regulation of bile acid, glycemic, lipid, and amino
acids.
In an effort to understand molecular basis of BCAA’s
function in cells, we examined the gene expression profiles
in mouse embryonic fibroblasts (MEF) in response to BCAA
starvation and replenishment. Unexpectedly, KLF15 was among
the dramatically regulated genes. In the present study, we
investigated the KLF15 regulation by BCAA. The results
demonstrated BCAA controls KLF15 expression through PI3K-
AKT signaling pathway.
MATERIALS AND METHODS
Animals
Wildtype C57BL/6 mice were purchased from SLAC Laboratory
Animals Company Limited, Shanghai, China. All animals
were housed at with a 12-h light, 12-h dark cycle with
free access to water and standard chow. This study was
carried out in accordance with the guidelines of the
Committee for Humane Treatment of Animals at Shanghai
Jiao Tong University School of Medicine. The protocol
was approved by the Committee for Humane Treatment
of Animals at Shanghai Jiao Tong University School of
Medicine.
Cell Culture
HepG2, NIH 3T3, and MEF cells were cultured in
Dulbecco’s modified Eagle’s medium (Hyclone, Beijing)
supplemented with 10% fetal bovine serum (FBS, Gibco BRL,
Gaithersburg, MD), penicillin (100 IU/mL) and streptomycin
(100µg/mL) in a humidified 5% CO2-95% air incubator
at 37◦C. Custom BCAA-free DMEM was provided by
Invitrogen. BCAA and BCKA chemicals were purchased
from Sigma.
Plasmids, Transfection, and Luciferase
Assays
The 3′UTR of mouse KLF15 was identified using the UCSC
Genome Browser (http://genome.ucsc.edu/) and cloned
into the psiCHECK_2 plasmid (Promega) with XhoI and
NotI sites, respectively. The 3’UTR fragment (921 bp) was
located in the 3′ flanking region of the synthetic Renilla
luciferase gene. Thus, Renilla luciferase expression can be
regulated by the downstream 3′UTR activity. The promoter
region of Klf15 (−5 kb before the translation start site in
the second exon) was cloned into PGL3 reporter vector
(Promega) (Jeyaraj et al., 2012). Plasmids were transfected using
lipofectimine2000 (Invitrogen) according to the manufacturer’s
protocol. The transfected cells were rinsed once with cold
PBS and lysed with passive lysis buffer (Promega) after
transfection for 24 h. Luciferase activity was measured using
the GloMax-Multi Detection System (Promega) and the
Dual-Luciferase Reporter Assay System (Promega). Renilla
luciferase expression was normalized to the expression of
firefly luciferase. Data are represented as means ± SE from
three biological replicates representing three independent
experiments.
RNA Extraction, Reverse Transcription and
Real-Time PCR Analysis
Total RNA was extracted using the Trizol (Invitrogen) according
to the manufacturer’s instructions. Total RNA (2 µg) was reverse
transcribed using random primers and MMLV (Promega). Each
cDNA sample was analyzed in triplicate with the Applied
Biosystems Prism7900HTReal-Time PCR System using Absolute
SYBR Green (ABI) with the specific primers. The relative
amount of specific mRNA was normalized by 18sRNA. Mouse
KLF15 primer sequences are: forward, 5′-TCTCGTCACCGA
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AATGCTCA-3′ and reverse, 5′-GAGTCAGGGCTGGCACAA
GA-3′.
Western Blot Analysis
Proteins from tissue or cells were harvested in buffer
(50mM HEPES [pH7.4], 150mM NaCl, 1% NP-40, 1mM
EDTA, 1mM EGTA, 1mM glycerophosphate, 2.5mM
sodium pyrophosphate 1mM Na3VO4, 20mM NaF, 1mM
phenylmethylsulfonyl fluoride, 1µg/mL of aprotinin,
leupeptin, and pepstatin). Samples were separated on
4–12% Bis-Tris gels (Invitrogen), and transferred onto
a nitrocellulose blot (Amersham). The blot was probed
with the indicated primary antibodies. Protein signals
were detected using conjugated secondary antibodies and
enhanced chemiluminescence (ECL) western blotting detection
regents (Pierce). The BCKDK antibody (AV52131) was
purchased from sigma. Phospho-Akt (#4051 for pAKT Ser473
and #2965 for pAKT Thr308) and total AKT (#9272 for
AKT1,2,3) antibodies were purchased from Cell Signaling
Technology. β-actin antibody was purchased from Sigma
Chemical Co.
Determination of BCAA Concentration
Fifty microliter of plasma was precleared of protein by addition
of an equal volume of methanol, followed by two rounds of
centrifugation to precipitate protein. The supernatant (90%
recovery) was lyophilized and resuspended in 45 µl dH2O.
Standards (L-valine, L-leucine, L-isoleucine, L-allo-isoleucine)
were prepared from powder. 10mM stocks were made in dH2O
and serial pooled dilutions prepared. A 250µM stock of D3-
Leucine was also prepared in dH2O. 2 µl of standard or 2 µl
of sample was diluted in 50 µl of butanolic HCL in 1.5ml
tube, heated to 60◦C for 20min and then speed vacuumed
to dryness. The samples were resuspended in 200 ul of 50:50
dH2O:acetonitrile containing 0.1% formic acid. The samples
were analyzed by LC-MS/MS.
FIGURE 1 | BCAA negatively controls KLF15 expression. Quantitative PCR results of KLF15 in MEFs. (A) MEFs were cultured in BCAA-free DMEM for indicated time
before harvesting. (B) MEFs were cultured with different concentrations of BCAAs for 6 h before harvesting. (C) MEFs were cultured without BCAA (−) for 4 h followed
with or without (−) BCAA replenishment for extra 2 h before harvesting. (D,E), AML12 liver cell line (D) and C2C12 muscle cell line (E) were cultured with (+) or without
(−) BCAA for 4 h before harvesting. Data are means ± SE for three individual samples. *p < 0.05, **p < 0.01.
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Statistical Analysis
Unless otherwise specified, statistical analyses were performed
with Student’s t-test (two groups) or one-way ANOVA (>2
groups) where appropriate. Data are calculated as the mean ±
SE (standard error) unless otherwise indicated. A p-value of less
than 0.05 was considered statistically significant.
RESULTS
KLF15 Expression Is Negatively Controlled
by BCAAs
To verify the KLF15 regulation by BCAAs identified in
gene expression profiles of MEF (data not shown), we
examined the time course of KLF15 expression following
BCAA deprivation. In commercial Dulbecco’s Modified Eagle’s
Medium (DMEM), the BCAAs concentration is 800µM. A
customized DMEM containing all components except for
BCAAs was used to deprive BCAA. In MEFs, KLF15 mRNA
demonstrated a clear increase at 2 h after BCAA deprivation,
and remained elevated for at least 10 h (Figure 1A). Further
study showed that BCAA suppressed KLF15 expression in
a dose-dependent way (Figure 1B). To further verify the
suppression of BCAA on KLF15 expression, we starved the
cells with BCAA-free DMEM and then replenished with
BCAA. BCAA replenishment clearly inhibited the BCAA-
deprivation-induced KLF15 expression (Figure 1C). KLF15
induction by BCAA starvation was also observed in other cell
FIGURE 2 | BCAA but not their catabolites regulate KLF15 expression. (A,B) Quantitative PCR results of BCAT2 (A) or KLF15 (B) in MEFs with Bcat2 silencing using
shRNA. (C) Quantitative PCR results of KLF15 in MEFs with Bcat2 silencing with or without BCKA (500µM) or 800µM BCAAs replenishment for 2 h after 4-h BCAA
starvation (−). *p < 0.05, **p < 0.01.
FIGURE 3 | BCAA starvation induces AKT phosphorylation. Measurements of Ser473 or Thr308 phosphorylation of AKT (pAKT) or total AKT (60KD band) using
immunoblots. (A) MEF cells were treated with BCAA deprivation (−) for indicated time. (B) MEF cells were treated with different concentrations of BCAAs for 2 h. Data
showed 1 experiment representative of 3.
Frontiers in Physiology | www.frontiersin.org 4 October 2017 | Volume 8 | Article 853
Liu et al. BCAA Controls KLF15 Expression
types, such as liver (AML12) and muscle (C2C12) cell lines
(Figures 1D,E).
BCAA but Not Their Catabolites Regulate
KLF15
BCAA can be catabolized in cells. BCAA and their catabolites
such as BCKA and 3-hydroxyisobutyrate exert various
physiological and pathological functions (Lynch and Adams,
2014; Jang et al., 2016). We then explored whether BCAA or
their catabolic intermediates affected the KLF15 expression.
Branched-chain amino acid transaminase 2 (BCAT2) catalyzes
the first reaction of BCAA catabolism. If the BCAT2 expression
is abolished, BCAA can’t be catalyzed into BCKA and other
intermediates. When BCAT2 expression was silenced by siRNA
in NIH-3T3 cell (Figure 2A), KLF15 expression was not affected
(Figure 2B). Meanwhile, In the BCAT2 knockdown cell, KLF15
expression was induced by BCAA deprivation, which was
inhibited by replenishing BCAA (Figure 2C). Thus, BCAA, but
not BCKA or downstream catabolites, suppressed the expression
of KLF15.
BCAA Starvation Activates PI3K-AKT
Signaling Pathway
We then explored the signaling pathway(s) involved in KLF15
regulation by BCAA. A recent study showed that amino acid
starvation activated PI3K/AKT signaling (Tato et al., 2011). PI3K
is a key signaling molecule to transduce extracellular signals to
regulate gene expression in a variety of cell types. AKT is a
well-known downstream target of PI3K and its activation can be
measured by phosphorylation at signature sites Ser473 or Thr308.
To address whether BCAA deprivation activated PI3K pathway,
we determined the AKT phosphorylation at Ser473 and Thr308
in response to BCAA starvation. BCAA deprivation caused
significant AKT activation at 1 and 2 h (Figure 3A; Figure S1).
FIGURE 4 | Inhibitors of PI3K and AKT attenuate BCAA-starvation-induced KLF15 expression. (A) Measurements of Ser473 or Thr308 phosphorylation of AKT
(pAKT) or total AKT (60KD band) using immunoblots. Cells were pretreated 60min with 10µM LY294002 or 1µM Wortmannin before BCAA deprivation (−) for 2 h.
Data showed 1 experiment representative of 3. (B) Cells were pretreated 60min with 10µM LY294002 or 1µM Wortmannin before BCAA deprivation (−) for 4 h and
then harvested for measurement of KLF15 mRNA by quantitative PCR. (C) Measurements of Ser473 or Thr308 phosphorylation of AKT (pAKT) or total AKT (60KD
band) using immunoblots. Cells were pretreated 60min with 10µM AKT inhibitor MK-2206 before BCAA deprivation (−) for 2 h. Data showed 1 experiment
representative of 3. (D) Cells were pretreated 60min with 10µM AKT inhibitor MK-220 before BCAA deprivation (−) for 4 h and then harvested for measurement of
KLF15 mRNA by quantitative PCR. Data are means ± SE for three individual samples. *p < 0.05, **p < 0.01.
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BCAAs deprivation induced AKT activation in a dose-dependent
way (Figure 3B; Figure S2).
PI3K-AKT Signaling Mediates
BCAA-Starvation-Induced KLF15
Expression
Pharmacological inhibitors of PI3K were then used to determine
whether PI3K signaling pathway participated in BCAA-
deprivation-induced KLF15 expression. The basal level and
BCAA-starvation-induced Akt phosphorylation at Thr308
and Ser473 were blocked by LY294002 and Wortmannin,
demonstrating a clear inhibition of PI3K signaling (Figure 4A;
Figure S3). Both LY294002 and Wortmannin abolished
BCAA-starvation-induced KLF15 expression (Figure 4B).
Similarly, AKT inhibitor MK-2206 inhibited AKT activation
(Figure 4C; Figure S4) and the KLF15 mRNA expression
induced by BCAA starvation (Figure 4D). Together, these
data support a critical role of PI3K-AKT signaling pathway in
BCAA-starvation-induced KLF15 expression.
BCAA Regulates KLF15 Expression at
Transcriptional Level
We then investigated whether BCAA starvation induced
KLF15 expression at transcriptional or post-transcriptional level.
Actinomycin D, an inhibitor of RNA synthesis, prevented
KLF15 induction by BCAA starvation (Figure 5A), suggesting
a transcriptional regulation. To investigate whether BCAAs
affected KLF15 expression at post-transcriptional level, we cloned
mouse KLF15 3’UTR fragments into the reporter vector p-
siCHECK_2, where Renilla luciferase expression is regulated by
downstream 3′UTR, and generated Luc-3′UTR reporters. After
transfecting this reporter vector into cells, the luciferase activity
was measured. The results showed that BCAA starvation did
not affect the expression of the luciferase fused with mouse
FIGURE 5 | BCAA regulates KLF15 expression at transcriptional level. (A) Quantitative PCR was performed to measure the mRNA level of KLF15 in cells pretreated
with actinomycin D (5µg/ml) or DMSO for 30min before BCAA starvation (−) for 6 h. (B) Luciferase assay results from MEF cells transfected with luciferase reporter
vectors with (+) or without (−) KLF15 3’UTR with (+) or without BCAA (−). (C) Quantitative PCR was performed to measure the relative mRNA level of KLF15 in cells
treated with actinomycin D (5µg/ml) for indicated time in the presence (con) or absence of BCAA (BCAA starvation). Data are means ± SE for three individual
samples. **p < 0.01.
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FIGURE 6 | BCAA does not directly affect KLF15 promoter activity. Quantitative PCR was performed to measure the mRNA level of luciferase (A) or KLF15 (B) in cells
transfected with empty PGL3-basic or KLF15-promoter-driving luciferase constructs and treated with BCAA starvation (−) or dexamethasone for 24 h. Data are
means ± SE for three individual samples. *p < 0.05.
KLF15 3’UTR (Figure 5B). Meanwhile, BCAA starvation failed
to affect the half-life of KLF15 mRNA (Figure 5C). These data
suggest that BCAA starvation affect the KLF15 expression at
transcriptional but not post-transcriptional level.
BCAA Does Not Directly Regulate KLF15
Promoter Activity
A common mechanism of transcriptional regulation is promoter
activation. A chimeric construct of luciferase gene under the
control of KLF15 promoter was introduced into cells by transient
transfection (Jeyaraj et al., 2012). KLF15-promoter contains a
well-defined GRE for the transactivity by glucocorticoid receptor
(Shimizu et al., 2011). Unexpectedly, BCAA starvation failed
to increase the KLF15-promoter-driven luciferase activity (data
not shown). Meanwhile, the KLF15-promoter-driven luciferase
mRNA expression was also not induced by BCAA starvation
(Figure 6A) even BCAA starvation induced endogens KLF15
mRNA expression (Figure 6B). On the other hand, activation
of KLF15 promoter and mRNA were observed following
dexamethasone treatment (Figure 6). Thus, BCAA starvation
induced the KLF15 transcription without directly affecting
KLF15 promoter activation.
BCAA Abundance Is Negatively Associated
with KLF15 Expression in Vivo
We further investigated the relationship between BCAA and
KLF15 expression in vivo. Plasma BCAA levels significantly
decreased after 12-h fasting (Figure 7A). We measured the
KLF15 expression in different tissues in fasted mice. KLF15
expression was significantly induced in muscle and white adipose
tissue, but not in liver (Figure 7B). These data suggest that, in
vivo, BCAA abundance was negatively associated with KLF15
expression.
DISCUSSION
Our data demonstrated that KLF15 expression is negatively
controlled by BCAA. BCAA starvation induced KLF15
expression. The regulation occurs at transcriptional level
although KLF15 promoter activity was not directly controlled
by BCAA. Interestingly, BCAA starvation induced PI3K-AKT
signaling that mediated KLF15 expression. In addition to the
cellular studies, we further showed that BCAA abundance is
negative associated with KLF15 expression in vivo. Considering
the critical roles of KLF15 in numerous cellular functions, these
data suggested BCAA could play roles in metabolic regulation
through controlling KLF15 expression.
It has been well established that BCAA, particularly leucine,
positively regulates mTOR activity. The mechanism was revealed
only recently, showing leucine directly interacts with its sensor
Sestrin2 and activates mTOR via numerous protein-protein
interactions on the surface of lysosome (Saxton et al., 2016;
Wolfson et al., 2016). In this way, BCAA, particularly leucine,
positively regulates TORC1 activity independent of AKT activity.
On the other hand, insulin and other growth factors induced
mTOR via activating PI3K-AKT pathway (Saxton and Sabatini,
2017). In the present study, BCAA starvation reduced TORC1
activity (data not shown). Therefore, it is interesting to find
Frontiers in Physiology | www.frontiersin.org 7 October 2017 | Volume 8 | Article 853
Liu et al. BCAA Controls KLF15 Expression
FIGURE 7 | Fasting leads to lower BCAA abundance and higher KLF15 expression in vivo. Mice at 10-week of age were fasted for 12 h. Plasma levels of BCAAs were
measured (A, n = 7 in each group) and mRNA level of KLF15 in different tissues were analyzed with quantitative PCR (B, n = 4 in each group). *p < 0.05, **p < 0.01.
that BCAA starvation induced PI3K-AKT activity while reducing
mTOR activity. Further investigations are warranted to elucidate
howBCAA-regulated PI3K-AKT and Sestrin2 pathways crosstalk
to determine the mTOR activity.
Our results showed that BCAA regulates KLF15 mRNA
expression at transcriptional level, illustrated by the inhibition
from actinomycin D and lack of activity by KLF15 3′UTR.
However, the KLF15 promoter-driving luciferase expression was
not affected by BCAA starvation even though the endogenous
KLF15 mRNA is induced. The KLF15 promotor used in the
current study has highGC content. It is possible that the structure
of KLF15 promoter in the plasmid impaired the response to
BCAA starvation. On the other hand, epigenetic changes induced
by BAA starvation has been reported (Chaveroux et al., 2010).
Amino acid starvation induces the transcription of numerous
genes such as CHOP, ATF3, and TRB3, a process associated with
modifications of histone acetylation and chromatin structure.
The KLF15 promoter activation may require epigenetic changes,
which remains to be further explored.
The KLF15 induction in response to BCAA starvation appears
to be cell type specific. Among different cell types, liver cell line
such as AML12 showed the weakest increase of KLF15 mRNA
in response to BCAA starvation. The KLF15 mRNA in AML12
was induced∼1.8-fold by BCAA deprivation, compared to more
than 5-fold induction in other cell types (Figure 1). Similarly,
in liver, the KLF15 expression showed a trend for increase in
response to fasting, whereas the KLF15 induction was more
significant in skeletal muscle and white adipose tissue. This cell-
type-specific KLF15 induction indicated diverse BCAA sensing
mechanisms and responses to BCAA nutrient in different cells
and tissues.
In conclusion, our data showed that BCAA negatively regulate
KLF15 expression. Dysfunctional BCAA homeostasis has been
linked with metabolic, neurological, cancer, and cardiovascular
diseases three regulation by BCAA strongly indicates a novel
mechanism for BCAA’s roles in different physiological processes.
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